Our team

“Ron Peleg’s expertise in product liability and navigating complicated industries is unmatched”
Chambers and Partners, Dispute Resolution: class action (Defense) 2024

“Ron Peleg is ‘Mr Pharmaceutical Litigation’ in Israel. He understands the industry incredibly well and is literally the best pharmaceutical class action lawyer in Israel”
Legal 500, Dispute Resolution 2024

“Ron Peleg wins plaudits as “Israel’s leading pharmaceutical products lawyer”
Who’s who legal Product Liability Defence 2021

“Ron Peleg is known as ‘Mr. Pharmaceutical Products Liability in Israel’, with impressed commentators opining that he ‘has become the absolute go-to lawyer in Israel’ for such work”
Who’s who legal Life Sciences 2021

“The ‘top-notch’ Ron Peleg is a guru in the pharmaceutical and automotive product liability areas, offering clients authoritative representation in high level class actions and other disputes”
Who’s who legal Product liability Defence 2019

“Ron Peleg is ‘The top name in Israel’ according to one peer. He provides clients with ‘very timely advice’ on a range of issues in the [pharmaceutical] field and is said to ‘know his way around the courts well'”
Who’s who legal Life Sciences 2019

Ron Peleg is an “excellent, smart and sophisticated litigator” who is praised for his work in pharmaceuticals. Sources state that “there is no comparison” and that he has “really tremendous experience in successfully defending multinationals” with “great legal skills and a confident, smart approach”.
Who’s who Product liability Defence 2018

Ron Peleg is a partner in the firm’s Litigation Group. Ron’s practice focuses on product liability, class actions, Pharmaceutical, Automotive, Regulatory Administrative and Commercial law His clients include leading multinationals and local, companies and manufacturers. Ron commonly handles high profile, complex, cross border litigation.

Ron is the former Associate Editor of the “Tel Aviv University Law Review”.

Ron has been selected as a leading practitioner by “Who’s Who Legal” in Product Liability (since 2010) and Life Sciences (since 2014). Also selected by WWL as a “Thought Leader” in life science (2019).

• Defense of Merck in individual and class actions concerning the drugs Vioxx, Propecia and Gardasil.
• Defense of GSK in class actions concerning the drugs: Avandia, Eltroxin and Zantac.
• Defense of AstraZeneca in a class action concerning the drug Crestor.
• Defense of Bayer in a class action concerning the contraceptives Yasmin&Yaz.
• Defense of Pfizer in a class action concerning the drug Champix.
• Defense of Novo Nordisk in a class action concerning the drug Saxenda.
• Defense of Eisai in a consumer class action concerning the drug Belviq.
• Defense of Monsanto and Bayer in a class action concerning agrochemical product “Round-Up”.
• Defense of Eli Lilly in a class action concerning the drug Zyprexa.
• Defense of Volkswagen and Audi in class actions regarding Diesel emission matter.
• Defense of VW Group and Champion Motors in consumer class actions.
• Defense of Renault Group in consumer class actions.
• Defense of Isuzu in a class action regarding behavior of diesel engines.
• Defense of Suzuki in consumer class actions.
• Defense of BYD and Shlomo Motors in a consumer class action.
• Defense of Expedia and Hotels.com in consumer class actions.
• Defense of a leading multinational electronics company in consumer class actions.
• Representation of the innovative stent manufacturer Medinol in its multibillion-dollar dispute with Boston Scientific.

• Co-author (with Noam Gilon) of the article ” ‘Breach of Autonomy’- A Unique Israeli Damages Theory” (For The Defense, September 2018). For the full article, click here.
• Panelist in WWL: Product Liability Defence 2018 roundtable. For the full article, click here.
• Co-author (with Noam Gilon) of the article “The Rise of Class Action in Israel” (In-House Defense Quarterly, Fall 2017). For the full article, click here.
• Co-author (with Dr. Israel Leshem and Edan Laron) of the Israeli chapter in: “The Chambers Legal Practice Guide: Litigation 2014-15”.
• Co-author (with Dr. Israel Leshem) of the Israeli chapter in: “The International Comparative Legal Guide to: Class and Group Actions 2010, A practical insight to cross-border Class and Group Actions work”. Published by Global Legal Group, London. http://www.iclg.co.uk. For the full article, click here.
• Co-author (with Dr. Israel Leshem) of the Israeli chapter in: “The International Comparative Legal Guide to: International Arbitration 2009”, A practical insight to cross-border international arbitration work. Published by Global Legal Group, London. http://www.iclg.co.uk/. For the full article, click here.
• Co-author (with Gilad Schiff) of the Israeli chapter in: “The International Comparative Legal Guide to Pharmaceutical Advertising 2009- A practical insight to cross-border Pharmaceutical Advertising work”. Published by Global Legal Group, London. http://www.iclg.co.uk/. For the full article, click here.
• Co-author (with Dr. Israel Leshem) of The Israeli Chapter in: “The International Comparative Legal Guide to: Litigation and Dispute Resolution 2009”, A practical insight to cross-border litigation and dispute resolution. Published by Global Legal Group, London. http://www.iclg.co.uk. For the full article, click here.